跳至主要内容
临床试验/IRCT201205219823N1
IRCT201205219823N1已完成3 期

Evaluation of probiotic effect on growth indicators and quality of life in children with Cystic Fibrosis

Vice Chancellor of Research, Mashhad University of Medical Sciences0 个研究点目标入组 37 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 12 years(—)
性别
All

入选标准

  • Ages 2 to 12 years old; Cystic Fibrosis disease confirmed by sweat testing, clinical symptoms and common mutations. Exclusion criteria: Patient intolerance to the medication; A lack of parental consent; Inability of probiotic consumption because of severe disease.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor of Research, Mashhad University of Medical Sciences

相似试验